Atlas Trials

Phase I Study Of PLM-102 In Patients With Relapsed And Refractory Acute Myeloid Leukemia

Clinical trial NCT07549464 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07549464
Sponsor
M.D. Anderson Cancer Center
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Acute Myeloid Leukemia
Start date
2026-10-01
Primary completion
2029-06-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.